heading for medica 2013 in düsseldorf, page-10

GregMcSnossage - I would be interested yo hear your views on Geoff mentioning the $10m potential royalties to ADO for either of the POC Companies.

My question to you is - Do you consider Geoff would be being rather conservative with his estimates?

With the POC market growing so rapidly surely this $10m could quite easily become $20m in 5 years time?

Also with Alere being the market leader - With ALERE having a rough 40% share of the lateral flow rapid test market - Do you think competitors will quickly move to adopt MIXNGO as well or do you think Alere may be looking for a period of exclusivity in the lateral flow market?